NCT02500121 · Interventional trial
Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer
Overall registry status Completed
Phase 2
Conditions Bladder Cancer, Urothelial Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory